echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Japan has invented a technique for using human-induced pluripotent stem cells to grow myocardial cells in large quantities.

    Japan has invented a technique for using human-induced pluripotent stem cells to grow myocardial cells in large quantities.

    • Last Update: 2020-08-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Japanese researchers have developed a technique that uses human-induced pluripotent stem cells to grow myocardial cells in large quantities.
    artificially induced heart muscle cells can help repair damaged hearts, as can "make stickers", and could be used in the future for heart disease treatment.
    induced pluripotent stem cells, which are "reprogrammed" to mature body cells, have similar differentiation potential to embryonic stem cells.
    Japan's Qingying University recently announced that the university researchers improved the experimental method, the length and width of about 30 cm and 20 cm of induction pluripotent stem cell dishes superimposed into 10 layers, forming a special multi-layer culture device, and invented a breathing system, evenly deliver oxygen and carbon dioxide to it, successfully cultivate about 1 billion cardiomyopathy cells at a time.
    heart diseases such as myocardial infarction can cause the heart to lose hundreds of millions of myocardial cells, which do not regenerate.
    Induced pluripotent and embryonic stem cells have the function of differentiated into multiple cells in the body, and the medical community is trying to replace dead heart muscle cells and repair damaged hearts by using artificially induced heart muscle cells as "creative".
    , however, there has been a lack of technology to grow high-safety heart muscle cells.
    latest results from Japanese researchers published in the new issue of the American Journal of Stem Cell Reports.
    university plans to conduct clinical trials next year to use the technology in the treatment of heart disease.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.